C41H45N5O7S — CID 59951193
(2R)-6-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]-2-[2-oxo-2-[4-[3-(4-prop-2-enoxycarbonylphenyl)indazol-1-yl]phenyl]ethyl]hexanoic acid (PubChem CID 59951193) has the molecular formula C41H45N5O7S and a molecular weight of 751.91 g/mol. Its IUPAC name is (2R)-6-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]-2-[2-oxo-2-[4-[3-(4-prop-2-enoxycarbonylphenyl)indazol-1-yl]phenyl]ethyl]hexanoic acid.
| Compound Name | (2R)-6-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]-2-[2-oxo-2-[4-[3-(4-prop-2-enoxycarbonylphenyl)indazol-1-yl]phenyl]ethyl]hexanoic acid |
|---|---|
| PubChem CID | 59951193 |
| Molecular Formula | C41H45N5O7S |
| Molecular Weight | 751.91 g/mol |
| Exact Mass | 751.30 |
| IUPAC Name | (2R)-6-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]-2-[2-oxo-2-[4-[3-(4-prop-2-enoxycarbonylphenyl)indazol-1-yl]phenyl]ethyl]hexanoic acid |
| SMILES | C=CCOC(=O)c1ccc(-c2nn(-c3ccc(C(=O)C[C@@H](CCCCNC(=O)CCCCC4SCC5NC(=O)NC54)C(=O)O)cc3)c3ccccc23)cc1 |
| InChI | InChI=1S/C41H45N5O7S/c1-2-23-53-40(51)28-16-14-27(15-17-28)37-31-10-3-4-11-33(31)46(45-37)30-20-18-26(19-21-30)34(47)24-29(39(49)50)9-7-8-22-42-36(48)13-6-5-12-35-38-32(25-54-35)43-41(52)44-38/h2-4,10-11,14-21,29,32,35,38H,1,5-9,12-13,22-25H2,(H,42,48)(H,49,50)(H2,43,44,52)/t29-,32?,35?,38?/m1/s1 |
| InChIKey | ZTXWFRVZGYPOSO-ZLGOTKINSA-N |
| XLogP | 6.32 |
| TPSA | 168.72 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 54 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 751.91 |
| LogP ≤ 5 | 6.32 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 9 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'biotin_analogue', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|